PetIQ Inc (PETQ)
17.04
+0.20
(+1.19%)
USD |
NASDAQ |
May 03, 16:00
17.02
-0.02
(-0.09%)
Pre-Market: 20:00
PetIQ Cash from Financing (TTM): -10.19M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -10.19M |
September 30, 2023 | -10.13M |
June 30, 2023 | -18.99M |
March 31, 2023 | -39.66M |
December 31, 2022 | -13.71M |
September 30, 2022 | -1.933M |
June 30, 2022 | -9.763M |
March 31, 2022 | 28.03M |
December 31, 2021 | 48.33M |
September 30, 2021 | 38.39M |
June 30, 2021 | 44.23M |
March 31, 2021 | 97.71M |
December 31, 2020 | 128.76M |
September 30, 2020 | 121.41M |
June 30, 2020 | 287.48M |
Date | Value |
---|---|
March 31, 2020 | 202.35M |
December 31, 2019 | 135.06M |
September 30, 2019 | 205.78M |
June 30, 2019 | 51.52M |
March 31, 2019 | 48.55M |
December 31, 2018 | 140.97M |
September 30, 2018 | 75.11M |
June 30, 2018 | 106.78M |
March 31, 2018 | 116.74M |
December 31, 2017 | 35.37M |
September 30, 2017 | 38.18M |
June 30, 2017 | -2.438M |
March 31, 2017 | 15.80M |
December 31, 2016 | 0.692M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-39.66M
Minimum
Mar 2023
287.48M
Maximum
Jun 2020
67.61M
Average
44.23M
Median
Jun 2021
Cash from Financing (TTM) Benchmarks
Dynavax Technologies Corp | 1.386M |
Pacira BioSciences Inc | -183.03M |
Supernus Pharmaceuticals Inc | -397.88M |
Esperion Therapeutics Inc | 50.46M |
Deciphera Pharmaceuticals Inc | 152.00M |